Proyectos de ley › 90.ª Asamblea General

Dónde está ahora

  1. Hecho: Presentado7 de febrero de 2023
  2. Hecho: Subcomité7 de febrero de 2023
  3. Hecho: Comité de la Cámara21 de febrero de 2023
  4. Se saltó: Lo aprueba la CámaraSigue como HF 423
  5. Sigue: Comité del Senado
  6. Sigue: Lo aprueba el Senado
  7. Sigue: A gobernador(a)
  8. Sigue: Firmado como ley

Ahora es HF 423 → Sigue avanzando con el número nuevo. Ir a HF 423 ¿Qué es el embudo (funnel)?

Qué contiene

Resumen con IA Insurance companies and pharmacy managers cannot treat certain healthcare providers differently just because they participate in the 340B drug discount program. These companies are prohibited from paying these providers less for drugs or fees than they pay other similar pharmacies. They also cannot place unfair restrictions on patients who choose to get their medicine through these specific providers. (Todavía no está traducido al español.)1

Lea la explicación oficial (en inglés)

This bill relates to contract pharmacies and covered entities that participate in the 340B program. The bill defines “340B program”, “contract pharmacy”, and “covered entity”. _____ Group health plans (plans), health carriers that offer group or individual health insurance coverage (carriers), third-party administrators (administrators), and pharmacy benefits managers (PBM) are prohibited from discriminating against a covered entity or a contract pharmacy by reimbursing the covered entity or the contract pharmacy for a prescription drug or a dispensing fee in an amount less than the plan, carrier, administrator, or PBM reimburses a similarly situated entity or pharmacy that is not a covered entity or a contract pharmacy. “Similarly situated entity or pharmacy” is defined in the bill. Plans, carriers, administrators, and PBMs shall not, on the basis that an entity is a covered entity or that a pharmacy is a contract pharmacy, or that a covered entity or contract pharmacy participates in the 340B program, impose certain contractual terms and conditions, as described in the bill, on the covered entity or contract pharmacy that differ from those imposed on a similarly situated entity or pharmacy that is not a covered entity or a contract pharmacy. Plans, carriers, administrators, and PBMs are also prohibited from placing restrictions or imposing requirements on individuals that choose to obtain a covered outpatient drug from a covered entity or a contract pharmacy, whether in person, via courier or the United States post office, or any other form of delivery; refusing to contract with a covered entity or a contract pharmacy based on any criteria that is not applied equally to a contract with a similarly situated entity or pharmacy that does not participate in the 340B program; or imposing any restriction or condition on a covered entity that interferes with the covered entity’s ability to maximize the value of the discounts obtained by the covered entity through the covered entity’s participation in the 340B program. “Group health plan” and “third-party administrator” are defined in the bill. _____ enforce compliance with the bill.7 upon a finding that a plan, a carrier, an administrator, or a PBM violated any provision of the bill.4(3). The commissioner may adopt rules as necessary to implement the bill. If any provision of the bill is inconsistent or in conflict with applicable state or federal law or rule, or the state Medicaid plan, the state or federal law or rule, or the state Medicaid plan, shall prevail to the extent necessary to eliminate the inconsistency or conflict. The bill applies to covered entities, contract pharmacies, plans, carriers, administrators, and PBM, but shall not apply to their operations under a contract with the state Medicaid agency or a Medicaid managed care organization, regardless of whether the covered entity or contract pharmacy is eligible to retain the 340B discounts generated by the covered entities and contract pharmacies. “Medicaid managed care organization” is defined in the bill.

Texto completo del proyecto (en inglés) · Qué cambió antes de aprobarse2

House subcommittee

Named February 7, 2023. On February 8, 2023 it recommended passage. Vote Total: 3-0.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Nota fiscal

Resumen con IA This bill prohibits insurance plans, carriers, and pharmacy benefit managers from discriminating against pharmacies or entities participating in the 340B drug program. While the Iowa Insurance Division will not need to hire new staff to enforce these rules, the bill has the potential to generate increased costs to the State of Iowa and the State of Iowa health plan. The exact fiscal impact of these changes is unknown. (en inglés)3

Lea la nota fiscal (en inglés)

Description

Senate File 419 relates to contract pharmacies and covered entities that participate in the 340B drug program and does the following:

  • Defines terms.
  • Prohibits plans, carriers, third-party administrators (TPAs), and pharmacy benefits managers (PBMs) from providing discriminatory reimbursement amounts for prescription drugs or dispensing fees on the basis of a covered entity’s or a contract pharmacy’s status as a covered entity or contract pharmacy.
  • Prohibits discrimination on the basis of participation in a 340B drug program, in addition to the status as a covered entity or a contract pharmacy, for the following:
  • Imposing contractual terms and conditions, as specified in the Bill.
  • Placing restrictions or imposing requirements on an individual that chooses to obtain a covered outpatient drug from a covered entity or a contract pharmacy.
  • Refusing to contract with a covered entity or a contract pharmacy based on any criteria that is not applied equally.
  • Imposing restrictions that interfere with the ability to maximize discounts through participation in a 340B drug program.
  • Permits the Commissioner of Insurance to take enforcement action under the Commissioner’s authority to enforce compliance. After notice and hearing, the Commissioner may issue any order or impose any penalty pursuant to Iowa Code section 507B.7 upon finding a violation of this Bill.
  • Establishes that a violation of this Bill violates Iowa Code section 507B.4(3) pertaining to unfair or deceptive acts or practices in the business of insurance.
  • Permits the Commissioner to adopt rules implementing the provisions of this Bill.
  • Clarifies that if any provisions of this Bill are in conflict with applicable State or federal law, that the State or federal law will prevail to the extent necessary to eliminate the conflict.
  • Establishes applicability.

Background

The 340B drug program refers to the program created pursuant to the Veterans Health Care Act of 1992, codified as §340B of the federal Public Health Services Act.

Senate File 419 is estimated to impact approximately 25.8% of the Iowa population (822,000). This includes individual coverage, fully insured small and large employer groups, self-insured public employees, and the State of Iowa Plan.

Of the individuals not covered by the mandate, approximately 45.2% are covered by government-sponsored health insurance, 23.0% are covered by employer coverage that is governed by the federal Employee Retirement Income Security Act of 1974 (ERISA), and the remaining 6.0% are uninsured.

Assumption

The Iowa Insurance Division will not need to hire additional full-time equivalent (FTE) positions to enforce the provisions of this Bill.

Fiscal Impact

Senate File 419 has the potential to generate increased costs to the State of Iowa and the State of Iowa health plan, but the fiscal impact is unknown.

Sources

  • Board of Regents
  • Iowa Insurance Division, Department of Commerce
  • Legislative Services Agency
  • Wellmark

Cómo leer una nota fiscal4

Lo que cambia del Código de Iowa (Iowa Code)

Crea§510D.1§510D.2§510D.3§510D.4§510D.5§510D.6

Modifica§507B.4

Cómo funciona el Código5

Cabildeo

19 a favor · 1 en contra · 16 indecisos · Quiénes →

Family tree